Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

  • There is currently no data for OVB

CEO Appointment and Board Changes

2 Dec 2009 11:42

RNS Number : 4586D
Ovoca Gold PLC
02 December 2009
 

Ovoca Gold plc ("Ovoca" or the "Company")

CEO Appointment and Board Changes 

Ovoca is pleased to announce that Tim McCutcheon has been named CEO effective immediately. Tim has been a director of Ovoca since January 2009. Mikhail Mogutov, will step down as CEO and become Executive Chairman, while the current Chairman Leonid Skoptsov will retain his position on the Board as a non-executive director. 

Tim has lived and worked in Russia and the Commonwealth of Independent States since 1994. Prior to working in Ovoca, Tim worked in multiple financial institutions such as Bear Stearns, Aton Capital and Pioneer Investments as an award-winning metals and mining sector analyst and as an investment bankerTim was one of the first analysts in Russia to write about its gold mining sector and he has advised numerous international gold mining companies on M&A, business development, and Russian business practices

Tim has a BA and MBA from Columbia UniversityNew YorkUSA. He lives in MoscowRussia and speaks fluent Russian.

Mr. McCutcheon commented "Given the recent surge in the gold price and increasing interest in the gold mining sector from investors globally, I believe now is a particularly fortuitous time to lead a gold mining company. It is clear that investors have been patient with the Company as it has re-grouped after the sale of Goltsovoye. I intend to reward shareholders for their patience by focusing on long term, sustainable shareholder valuelook forward to advancing Ovoca and putting its human and capital resources to work."

Mr. Mogutov comments "I am pleased that we were able to attract someone of Tim's calibre to lead Ovoca. Tim is set to quickly form a wider management team, look to acquire new assets and to vigorously advance the company. It has been almost a year since Ovoca sold its core asset Goltsovoye. The Company has cash and technical expertise, and with Tim's appointment we now have a leader to tie everything together to make a vibrant, successful company.

I will take over my previous position as Chairman and would like to thank Mr. Skoptsov for his work in that capacity." 

For further information please visit www.ovocagold.com or contact:

Ovoca Gold plc

Timothy McCutcheon +7 495 916 6029 tim.mccutcheon@ovocagold.com

Mr Danesh Varma, CFO +44 207 653 9881 danesh.varma@ovocagold.com

Davy 

John Frain +353 1 679 6363

End

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADGMGZMZGGLZM
Date   Source Headline
29th Jul 20227:00 amRNSCompletion of Enrollment in Phase II Study
30th Jun 20227:00 amRNSAnnual Financial Report
7th Mar 20229:00 amRNSStatement re Russian Business Operations
23rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
22nd Feb 20223:30 pmRNSRussian Marketing Authorisation for Orenetide
31st Jan 20227:00 amRNSBoard Changes and Update
30th Dec 20217:00 amRNSDirectorate Change
4th Nov 20213:53 pmRNSHolding(s) in Company
4th Nov 20213:50 pmRNSDirector/PDMR Shareholding
4th Nov 20213:46 pmRNSBoard Change
14th Sep 20217:00 amRNSInterim Results
29th Jul 20215:00 pmRNSResult of AGM
24th Jun 20217:00 amRNSAnnual Report and Notice of AGM
10th Mar 20217:00 amRNSMigration of Participating Securities
16th Feb 20212:00 pmRNSResult of EGM
29th Jan 20217:00 amRNSFirst Patient Enrolled in Phase II Study - BP-101
25th Jan 20213:30 pmRNSNotice of EGM
5th Jan 20217:00 amRNSRe-Filing of Marketing Authorisation Application
17th Dec 20202:45 pmRNSResult of AGM
27th Nov 20203:08 pmRNSNotice of AGM
9th Oct 20207:00 amRNSAppointment of Chief Business Officer
2nd Oct 202011:06 amRNSSecond Price Monitoring Extn
2nd Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20209:05 amRNSSecond Price Monitoring Extn
2nd Oct 20209:00 amRNSPrice Monitoring Extension
2nd Oct 20207:00 amRNSUpdate re Russian Marketing Authorisation
28th Sep 20207:00 amRNSDeath of a Director
21st Sep 20207:00 amRNSInterim Results
14th Aug 202011:05 amRNSSecond Price Monitoring Extn
14th Aug 202011:00 amRNSPrice Monitoring Extension
26th Jun 20207:00 amRNSAnnual Report
14th Apr 20202:05 pmRNSSecond Price Monitoring Extn
14th Apr 20202:00 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNSAcquisition of Remaining Minority Interest in IVIX
7th Nov 201912:45 pmRNSAttendance at Bio-Europe Conference
16th Sep 20197:00 amRNSInterim Results
12th Sep 20197:00 amRNSFiling of Marketing Authorisation Application
28th Aug 20197:00 amRNSDirectorate Change
8th Aug 20194:14 pmRNSResult of AGM
8th Aug 20199:05 amRNSSecond Price Monitoring Extn
8th Aug 20199:00 amRNSPrice Monitoring Extension
8th Aug 20197:00 amRNSAGM Statement
26th Jul 20197:00 amRNSDirectorate Change
25th Jul 20194:41 pmRNSSecond Price Monitoring Extn
25th Jul 20194:35 pmRNSPrice Monitoring Extension
28th Jun 20197:00 amRNSAnnual Report and Notice of AGM
23rd Apr 20197:00 amRNSUS and EU Clinical Development Plans
29th Mar 20197:00 amRNSDirector/PDMR Shareholding
27th Mar 20197:00 amRNSOperational Update & Additional Investment in IVIX

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.